EP0816366A1 — Imidazothiazole compounds
Assigned to Kowa Co Ltd · Expires 1998-01-07 · 28y expired
What this patent protects
An imidazothiazole compound having the formula (A): wherein R 1 is a phenyl or napthyl which may have a substituent, R 2 is an acyl, and the two bonds at dotted line portions may or may not exist simultaneously, or a pharmacologically acceptable salt thereof and an agent for …
USPTO Abstract
An imidazothiazole compound having the formula (A): wherein R 1 is a phenyl or napthyl which may have a substituent, R 2 is an acyl, and the two bonds at dotted line portions may or may not exist simultaneously, or a pharmacologically acceptable salt thereof and an agent for overcoming resistance to an anti-neoplastic agent or an enhancer for the effect of an anti-neoplastic agent comprising said compound or a pharmacologically acceptable salt thereof as an active ingredient.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.